What Are the Effects of Lower Limb Dysmetria on Gluteus Medius and Erector Spinae Musculature? (s-EMG)

January 11, 2024 updated by: Camilo Jose Cela University

Changes in Activity of Erector Spinae and Gluteus Medius Mus-cles With the Presence of Simulated Lower Limb Dismetry

Gluteus Medius (GM) has also been implicated in the development of LBP. GM is one of the main pelvic, where he actively participates in control of motion in the frontal and transverse plane, and hip , improving stability to the lumbopelvic-hip complex.

The aim of present study was to investigate whether modifying lower limb length with a different foot insoles of 0.5, 1 and 1.5 cm in a normal population has an effect on ES and GM activity and as a consequence in LBP. As a secondary objective, in turn, to evaluate whether ES and GM activity has an effect on jumping ability as assessed through CMJ.

Study Overview

Detailed Description

Background: Lengt leg discrepancy (LLD), regardless of its origin, is a very common pathology that can contribute to low back pain. Various authors point out its relationship with the lack of acti-vation of both the gluteus medius (GM) and the ipsilateral erector spinae (ES). The purpose of this study was to identify the activation of Es and GM with different simulated LLD, correlating said activation with the LBP. In turn, to evaluate whether ES and GM activity has an effect on jumping ability as assessed through CMJ. (2) Method: a sample of healthy subjects was selected to whom an artificial LLD was incorporated through a 0.5, 1 and 1.5 cm insole, measuring with EMGs in these 3 moments while walking and performing a counter movement jump (CMJ). The measurement was carried out in random order, in terms of insole height, using a Latin Square. Muscle activation patterns were recorded for 30 seconds at each of the insole heights while walking at 5.7 km/h and compared with the maximum voluntary contraction (MVC), both on the ipsilateral and contra-lateral sides. These muscles were then measured under the same circumstances during the de-velopment of the CMJ. (3)

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Villanueva De La Cañada, Madrid, Spain
        • Juan Hernández Lougedo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

-

Exclusion Criteria:

  • The volunteers had no problems in range of motion of joints of the lower limbs
  • pelvic obliquity due to a functional leg length discrepancy.
  • obesity with body mass index (BMI) 35 > kg/m²

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Plantilla 0,5 cm
A template with the dimensions indicated is introduced to the user and he/she walks for 1 minute.
To evaluate the response of an orthopedic insole of different heights on gait.
To evaluate the response caused by an orthopedic insole of different heights on the indicated musculature.
Experimental: Plantilla 1 cm
A template with the dimensions indicated is introduced to the user and he/she walks for 1 minute.
To evaluate the response of an orthopedic insole of different heights on gait.
To evaluate the response caused by an orthopedic insole of different heights on the indicated musculature.
Experimental: Plantilla 1,5 cm
A template with the dimensions indicated is introduced to the user and he/she walks for 1 minute.
To evaluate the response of an orthopedic insole of different heights on gait.
To evaluate the response caused by an orthopedic insole of different heights on the indicated musculature.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height CMJ
Time Frame: 1 week
CMJ jump flight height
1 week
Height DJ LEFT
Time Frame: 1 week
Flying height in drop jump left leg
1 week
Height DJ RIGHT
Time Frame: 1 week
Flying height in drop jump right leg
1 week
Gluteus medius (mv)
Time Frame: 1 week
Gluteus medius activation (mv)
1 week
Erector Spinae (mv)
Time Frame: 1 week
Erector Spinae activation (mv)
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Eduardo Cimadevilla, PT, Camilo Jose Cela University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 20, 2023

Primary Completion (Actual)

June 3, 2023

Study Completion (Actual)

September 8, 2023

Study Registration Dates

First Submitted

December 4, 2023

First Submitted That Met QC Criteria

January 11, 2024

First Posted (Actual)

January 23, 2024

Study Record Updates

Last Update Posted (Actual)

January 23, 2024

Last Update Submitted That Met QC Criteria

January 11, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscular Disorders, Atrophic

Clinical Trials on To evaluate the response of an orthopedic insole

3
Subscribe